Stereotaxis (STXS) Net Margin (2010 - 2026)

Stereotaxis (STXS) reported Net Margin of 98.11% for Q1 2026, down 1598.0% year-over-year from 6.55% in Q1 2025, and down 44.96% quarter-over-quarter from 67.68% in Q4 2025.

Stereotaxis (STXS) Net Margin (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Net Margin data on file, last reported at 98.11% in Q1 2026.

  • Net Margin for Q1 2026 came in at 98.11%, down 1598.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 73.57% (up 2331.0% YoY), and the FY2025 annual result was 70.77%, up 2341.0% from the prior year.
  • Net Margin fell to 98.11% in Q1 2026 per STXS's latest filing, from 67.68% in the prior quarter.
  • Over five years, Net Margin peaked at 47.1% in Q2 2025 and troughed at 136.78% in Q2 2024.
  • A 5-year average of 83.2% and a median of 73.18% in 2023 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2022 and 2025: Net Margin sank 7182 bps in 2022, then surged 8968 bps in 2025.
  • A 5-year view of Net Margin shows it stood at 61.53% in 2022, then plunged by 92 bps to 117.83% in 2023, then dropped by 5 bps to 123.64% in 2024, then jumped by 45 bps to 67.68% in 2025, then plunged by 45 bps to 98.11% in 2026.
  • Business Quant data shows STXS's Net Margin at 98.11% in Q1 2026, 67.68% in Q4 2025, and 90.9% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 29.81%
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -5.81%
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 3.25%
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 27.86%
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 16.03%
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 0.65%
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -7.20%
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 10.84%
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 0.07%
10 Stereotaxis 180.48 Mn 165.86 Mn 3.79 Mn -98.11%

Historic Data

Download Data
DateValue
Mar 31, 2026 -98.11%
Dec 31, 2025 -67.68%
Sep 30, 2025 -90.90%
Jun 30, 2025 -47.10%
Mar 31, 2025 -82.13%
Dec 31, 2024 -123.64%
Sep 30, 2024 -70.88%
Jun 30, 2024 -136.78%
Mar 31, 2024 -70.32%
Dec 31, 2023 -117.83%
Sep 30, 2023 -73.18%
Jun 30, 2023 -67.34%
Mar 31, 2023 -86.71%
Dec 31, 2022 -61.53%
Sep 30, 2022 -68.64%
Jun 30, 2022 -88.90%
Mar 31, 2022 -62.77%
Dec 31, 2021 -44.81%
Sep 30, 2021 -54.44%
Jun 30, 2021 -17.08%